NEU 2.81% $18.65 neuren pharmaceuticals limited

Ann: 2023 Annual Report to shareholders, page-176

  1. 2,834 Posts.
    lightbulb Created with Sketch. 593
    We all have the opportunity to reinvest any or all of the monies from a t/o of Neuren in the acquiring company if we think it has gone for under the odds.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.